As a company grows and expands (whether by acquisition or organically), it can encounter issues which may prompt a divestiture.

A tremendous amount of capital has been, and continues to be, dedicated by private equity sponsors, and private equity backed companies, toward the recapitalization of physician practices. Here are seven important high-level considerations that may impact your approach to these transactions.

As a result of the CLOUD Act on April 17, 2018 the Supreme Court dismissed the US v. Microsoft case after hearing arguments on February 27, 2018 regarding Microsoft’s reliance on the 1986 SCA to refuse to produce emails in Ireland of an alleged drug dealer.

Foley’s Automotive Industry Team has prepared this report examining what the litigation, enforcement and regulatory landscape is likely to look like in 2018 and beyond.

As a life sciences or medical device company, it is mission critical to protect lab books, drug and clinical test data, product formulas and production processes that underlie your patents, trade secrets and know-how from hackers and others.